Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents

被引:1
|
作者
Reese, T [1 ]
Bochelen, D
Sauter, A
Beckmann, N
Rudin, M
机构
[1] Novartis Pharma Ltd, Core Technol, Preclin Res S386 201, CH-4002 Basel, Switzerland
[2] Novartis Pharma Ltd, Nervous Syst Dept, CH-4002 Basel, Switzerland
关键词
magnetic resonance angiography (MRA); time-of-flight MRA; rat brain; middle cerebral artery occlusion (MCAO); stroke; transient cerebral ischemia; reperfusion;
D O I
10.1002/(SICI)1099-1492(199906)12:4<189::AID-NBM557>3.0.CO;2-O
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We describe and discuss the application of three-dimensional (3D) time-of-flight (TOF) magnetic resonance angiography (MRA) to visualize non-invasively the cerebral vasculature of the rat. MR angiograms of healthy spontaneously hypertensive rats were obtained without the use of contrast agents. Total imaging time ranged from 1 to 50 min for a 3D data set. The influences of the data matrix and the inflow delay on the image quality and the total imaging time are assessed and discussed. Varying the inflow delay yielded in addition semiquantitative information on hemodynamics. The method was applied to obtain angiograms in rat models of permanent and temporal middle cerebral artery occlusion. Occlusion and reopening of the vessel could easily be verified by MRA. However, after reperfusion a slight reduction in blood flow was observed. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 50 条
  • [1] Magnetic resonance angiography without contrast agents
    Bock, M.
    [J]. RADIOLOGE, 2019, 59 (06): : 523 - 532
  • [2] MAGNETIC-RESONANCE ANGIOGRAPHY AND USE OF CONTRAST AGENTS
    HARTNELL, GG
    [J]. LANCET, 1992, 339 (8785): : 124 - 124
  • [3] Kontrastmittelfreie MagnetresonanzangiographieMagnetic resonance angiography without contrast agents
    M. Bock
    [J]. Der Radiologe, 2019, 59 : 523 - 532
  • [4] The use of contrast-enhanced, time-resolved magnetic resonance angiography in cerebrovascular pathology
    Grossberg, Jonathan A.
    Howard, Brian M.
    Saindane, Amit M.
    [J]. NEUROSURGICAL FOCUS, 2019, 47 (06) : 1 - 6
  • [5] Transport of contrast agents in contrast-enhanced magnetic resonance angiography
    Jou, LD
    Rapp, J
    Saloner, D
    [J]. MAGNETIC RESONANCE IMAGING, 2004, 22 (04) : 495 - 504
  • [6] Phase-contrast magnetic resonance angiography for the determination of cerebrovascular reserve
    Patrick, JT
    Fritz, JV
    Adamo, JM
    Dandonna, P
    [J]. JOURNAL OF NEUROIMAGING, 1996, 6 (03) : 137 - 143
  • [7] In-vivo phase contrast magnetic resonance angiography of the cerebrovascular system: a comparative study with duplex sonography
    Hsieh, Kety
    Stein, Katja
    Mono, Marie-Luise
    Kellner-Weldon, Frauke
    Verma, Rajeev Kumar
    Weisstanner, Christian
    Andereggen, Lukas
    Reinert, Michael
    Gralla, Jan
    Schroth, Gerhard
    El-Koussy, Marwan
    [J]. SWISS MEDICAL WEEKLY, 2015, 145
  • [8] Ferumoxytol Use as an Intravenous Contrast Agent for Magnetic Resonance Angiography
    Stabi, Katie L.
    Bendz, Lisa M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1571 - 1575
  • [9] Pediatric magnetic resonance angiography: to contrast or not to contrast
    Erin K. Opfer
    Nathan S. Artz
    Grace S. Mitchell
    Sherwin S. Chan
    [J]. Pediatric Radiology, 2023, 53 : 1364 - 1379
  • [10] Pediatric magnetic resonance angiography: to contrast or not to contrast
    Opfer, Erin K.
    Artz, Nathan S.
    Mitchell, Grace S.
    Chan, Sherwin S.
    [J]. PEDIATRIC RADIOLOGY, 2023, 53 (07) : 1364 - 1379